Latest Articles
Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes - The ASCO Post
Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes The ASCO Post
Published: Sept. 19, 2025, 2:23 p.m.
Acupuncture combined with Chinese herbal medicine versus Chinese herbal medicine alone to improve clinical efficacy in treating endometriosis-associated pain: a systematic review and meta-analysis - Frontiers
Acupuncture combined with Chinese herbal medicine versus Chinese herbal medicine alone to improve clinical efficacy in treating endometriosis-associated pain: a systematic review and meta-analysis Frontiers
Published: Sept. 19, 2025, 2:04 p.m.
Endometriosis listening event to be held this weekend - Manx Radio Motorsport
Endometriosis listening event to be held this weekend Manx Radio Motorsport
Published: Sept. 19, 2025, 1 p.m.
Signs of endometrial cancer you shouldn’t ignore - Geisinger Health System
Signs of endometrial cancer you shouldn’t ignore Geisinger Health System
Published: Sept. 19, 2025, 12:31 p.m.
Endometriosis listening event to be held this weekend - Manx Radio
Endometriosis listening event to be held this weekend Manx Radio
Published: Sept. 19, 2025, 12:19 p.m.
Elizabeth Amoaa, the Ambassador for ENDO1000 Project - CediRates
Elizabeth Amoaa, the Ambassador for ENDO1000 Project CediRates
Published: Sept. 19, 2025, 9:44 a.m.
Case study: Sydney’s landmark hosting of the 16th World Congress on Endometriosis - c-mw.net
Case study: Sydney’s landmark hosting of the 16th World Congress on Endometriosis c-mw.net
Published: Sept. 19, 2025, 8:59 a.m.
Elizabeth Amoaa, the Ambassador for ENDO1000 Project - MyJoyOnline
Elizabeth Amoaa, the Ambassador for ENDO1000 Project MyJoyOnline
Published: Sept. 19, 2025, 6:38 a.m.
Diagnosis and Surgical Management of Inguinal Endometriosis - medtalks.in
Diagnosis and Surgical Management of Inguinal Endometriosis medtalks.in
Published: Sept. 19, 2025, 4:33 a.m.
Latecomer Jemperli wins reimbursement race against Keytruda for endometrial cancer in Korea - koreabiomed.com
Latecomer Jemperli wins reimbursement race against Keytruda for endometrial cancer in Korea koreabiomed.com
Published: Sept. 19, 2025, 4:21 a.m.
Link copied to clipboard!